Technetium-99m ethylene dicysteine: A now renal tubular function agent

European Journal of Nuclear Medicine

Volumn 27, Issue 3, 2000, Pages 351-357

  Kabasakal, Levent ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Effective renal plasma flow; Radionuclide renography; Renal tubular agents; Technetium 99m ethylene dicysteine; Technetium 99m mercaptoacetyltriglycine

Indexed keywords

CYSTINE; ETHYLENE DERIVATIVE; N,N' ETHYLENEDICYSTEINE TC 99M; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ARTICLE; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG COST; DRUG ELIMINATION; DRUG UPTAKE; ERYTHROCYTE; HUMAN; IMAGE QUALITY; ISOTOPE LABELING; KIDNEY FUNCTION; KIDNEY TUBULE;

CYSTEINE; HUMANS; ORGANOTECHNETIUM COMPOUNDS; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; RENAL PLASMA FLOW, EFFECTIVE;

EID: 0034065493     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Welch TJC, Potchen EJ, Welch MJ (eds) Qualitative biomedical examples of tracer kinetics. In: Fundamentals of the tracer method. Philadelphia: Saunders, 1972.
2. Smith HW, Goldring W, Chasis H. The measurement of the tubular excretory mass, effective blood flow and filtration rate in the normal human kidney. J Clin Invest 1938; 17: 263.
3. Smith HW, Finkelstein N, Aliminosa L, Crawford B, Graber M. The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945; 24: 388-404.
4. 131 labeled hippuran in kidney function tests. Proc Soc Exp Biol Med 1960; 103: 497-500.
5. Walovitch RC, Cheesman EH, Maheu LJ, Hall KM. Studies of the retention mechanism of the brain perfusion imaging agent Tc-99m-bicisate (Tc-99m-ECD) J Cereb Blood Flow Metab 1994; 14 (Suppl): S4-S11.
6. Walovitch RC, Francescchi M, Cheesman EH, et al. Metabolism of Tc-99m-LL-ethyl cysteinate dimer in healthy volunteers. Neuropharmacology 1991; 30: 283-292.
7. Ozker K, Kabasakal L, Liu Y, Hellman RS, Isitman A, Krasnow AZ, Collier BD. Evaluation of Tc-99m-bicisate as a renal imaging agent. Nucl Med Commun 1997; 18: 771-775.
8. Van Nerom, Bormans G, De Beukelaer C, De Roo M, Verbruggen A. Metabolism of Tc-99m-ECD in organ homogeneates of baboon [abstract] Eur J Nucl Med 1989; 15: 423.
9. Verbruggen A, Nosco DD, Van Nerom C, Bormans G, Adriaens P, DE Roo M. Tc-99m L,L-ethylenedicysteine, a potential alternative to Tc-99m MAG3 [abstract] J Nucl Med 1990;31: 908.
10. Van Nerom C, Bormans G, Cleyhens B, Nosco D, De Roo M. Comparison of renal excretion characteristics of isomers L,L and D, of Tc-99m ethylenedicysteine [abstract] J Nucl Med 1990; 31: 806.
11. Taylor A, Hansen L, Eshima D, et al. Comparison of Tc-99m L,L-EC isomers in rats and humans. J Nucl Med 1997; 38: 821-826.
12. Mang'era KO, Vanbillioen HP, Bellande E, Pasqualini R, Verbruggen AM. Influence of a Tc-99m-N core on biological and physicochemical behavior of Tc-99m complexes of L,L-EC and L,L-ECD. Nucl Med Biol 1996; 23: 987-993.
13. Hansen L, Lipowska M, Marzilli LG, Taylor A Jr. A promising renal tubular function agent that combines the structural features of MAG3 and EC [abstract] J Nucl Med 1996; 37: 17p.
14. Verbruggen AM, Nosco DL, Van Nerom CG, Bormans GM, Adriaens PJ, De Roo MJ. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. J Nucl Med 1992; 33: 551-557.
15. Szilvasi I, Környei J, Nagy Z. Tc-99m-EC kit for dynamic renal scintigraphy, first clinical results [abstract]. Eur J Nucl Med 1992; 19: 617.
16. Surma MJ, Wiewiora J, Liniecki J. Usefulness of Tc-99m N,N-ethylene-I-dicysteine complex for dynamic kidney investigations. Nucl Med Commun 1994; 15: 628-635.
17. Van Nerom CG, Bormans GM, De Roo MJ, Verbruggen AM. First experience in healthy volunteers with technetium-99m-L,L-ethylenedicysteine, a new renal imaging agent. Eur J Nucl Med 1993; 20: 738-746.
18. Gupta NK, Bomanji JB, Waddington W, et al. Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disorders. Eur J Nucl Med 1995; 22: 617-624.
19. Kabasakal L, Turoglu HT, Onsel C, et al. Comparative continuous infusion renal clearance of Tc-99m EC, Tc-99m-MAG3 and I-131-OIH. J Nucl Med 1995; 36: 224-228.
20. Kabasakal L, Atay S, Vural AV, et al. Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio. J Nucl Med 1995; 36: 1398-1403.
21. Nielsen SS, Poulsen EU, Markversen J, Nielsen LE, Bacher T, Rehling M. Clearance and renal extraction of technetium-99m-I,I-ethylenedicysteine, I-131-orthoiodohippurate and I-125-iothalamate in pigs. Clin Physiol 1999; 19: 338-343.
22. Stoffel M, Jamar F, Van Nerom C, et al. Evaluation of technetium-99m-L,L-EC in renal transplant recipients: a comparative study with technetium-99m-MAG3 and iodine-125-OIH. J Nucl Med 1994; 35: 1951-1958.
23. Gutsche HU, Scheffler M, Muller-Suur R, Siegmund JB. Micropuncture study on filtration and reabsorption of Tc-99m-L,L-ethylenedicysteine in rats. Nucl Med Commun 1995; 16: 407.
24. Prulovich EM, Bomanji JB, Waddington WA, Rudrasingham P, Verbruggen A, Ell PJ. Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure. J Nucl Med 1997; 38: 809-814.
25. Kabasakal L, Halaç M, Alkan E, Özçelik N, Önsel C, Uslu I. Reproducibility of technetium-99m ethylenedicysteine clearance. Eur J Nucl Med 1999; 26: 900-902.
26. Kabasakal L, Ozker K, Isitman A, Onsel C. Relationship between the OIH and Tc-99m EC clearances. Nucl Med Commun 1994; 15: 1006-1007.
27. Kabasakal L, Erdil TY, Ayaz M, et al. Evaluation of Tc-99m EC in anuric hemodialysis patients. Ind J Nucl Med 1998; 13: 42-44.
28. Yapar AF, Kabasakal L, Dogruca L, Cimtas E, Onsel C. Determination of renal and extrarenal clearances of Tc-99m-EC [abstract]. Eur J Nucl Med 1997; 24: 898.
29. Ozker K, Onsel C, Kabasakal L, et al. A new technetium labeled renal agent Tc-99m-ethylenedicysteine: a comparative renal scintigraphic study with Tc-99m MAG3 and I-131-OIH in patients with obstructive renal disease. J Nucl Med 1994; 35: 840-845.
30. Sayman HB, Kanmaz B. Devranoglu G, et al. Evaluation of renal transplants by using Tc-99m-N,N-ethylenedicysteine - a comparative study with OIH [abstract] Eur J Nucl Med 1995; 22: 862.
31. Kibar M, Noyan A, Anarat A. Tc-99m-N,N-ethylenedicysteine scintigraphy in children with various renal disorders: a comparative study with Tc-99m MAG3. Nucl Med Commun 1997; 18: 44-52.
32. Ugur O, Caner B, Cekirge S, et al. The diagnosis of renovascular hypertension with technetium-99m-ethylenedicysteine captopril scintigraphy. Invest Radiol 1996; 31: 378-381.
33. Ugur O, Peksoy I, Caner B. Technetium-99m-ethylenedicysteine: an alternative agent to detect renovascular hypertension. J Nucl Med 1997; 38: 1662-1664.
34. Ugur O, Serdengecti M, Karacalioglu O, Ergun EL, Peksoy I, Cekirge S. Prediction of response to revascularization with renal artery stenosis by Tc-99m-ethylenedicysteine captopril scintigraphy. Ann Nucl Med 1999; 13: 77-81.
35. Kabasakal L, Yapar AF, Ozker K, Alkan E, Atay S, Ozcelik N, Onsel C. Simplified technetium-99m-EC clearance in adults from a single plasma sample. J Nucl Med 1997; 38: 1784-1786.
36. Kabasakal L, Halac M, Yapar AF, et al. Prospective validation of single plasma sample Tc-99m-ethylenedicysteine clearance in adults. J Nucl Med 1999; 40: 429-431.
37. Ciftci I, Erbas B. Estimation of Tc-99m-ethylenedicysteine clearance using single sample technique [abstract]. Eur J Nucl Med 1998; 25: 856.
38. Erbas B, Ciftci I. A new formula to estimate clearance of Tc-99m-EC using single sample method [abstract]. Eur J Nucl Med 1998; 25: 929.
39. Stoffel M, Jamar F, Van Nerom C, Verbruggen A, Besse T, Squifflet JP, Beckers C. Technetium-99m L,L-ethylenedicysteine clearance and correlation with iodine-125 orthoiodohippurate for the determination of effective renal plasma flow. Eur J Nucl Med 1996; 23: 365-370.